Ageism in health care delivery operates at both the health system and individual provider levels, causing adverse health ...
This article concludes a series of five articles on the final 2027 payment rule. It also covers a new lawsuit seeking to void ...
The classic cost-disease cure is to “productize” what used to be a service by substituting scalable goods. But in health care, the opportunity lies not in replacing services with goods but in raising ...
Policymakers should preserve the achievements of the Transcatheter Aortic Valve Replacement registry while recognizing that ...
AI will not determine whether American health care becomes more or less affordable. The payment system will determine that, ...
We should keep grading hospitals. We must also imagine measurement structures as intelligent as the systems they evaluate.
AI is increasingly moving from experimental settings into health care delivery. Improvements in AI have created growing ...
Hospitals that received poor grades did not respond with a pledge to improve quality; instead, they sued the messenger. They ...
This is part two of a two-part article offering proposals to improve the FDA’s draft guidance to implement a new approval ...
The DoJ intervened in the whistleblower lawsuit, alleging that the MA Organizations paid the broker defendants hundreds of ...
This is part one of a two-part article offering proposals to improve the FDA’s guidance to implement a new approval framework ...
Ultra-rare diseases often lack patient populations large enough to support randomized controlled trials. The question is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results